Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1376567 | Bioorganic & Medicinal Chemistry Letters | 2008 | 6 Pages |
Abstract
A series of pyrazolo[3,4-d]pyrimidine, pyrrolo[2,3-d]pyrimidine and 6-arylpurine adenosine A2A antagonists is described. Many examples were highly selective against the human A1 receptor sub-type and were active in an in vivo model of Parkinson’s disease.
Graphical abstractA series of pyrazolo[3,4-d]pyrimidine, pyrrolo[2,3-d]pyrimidine and 6-arylpurine adenosine A2A antagonists is described. Many examples were highly selective against the human A1 receptor sub-type and were active in an in vivo model of Parkinson’s disease.Figure optionsDownload full-size imageDownload as PowerPoint slide
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Roger J. Gillespie, Ian A. Cliffe, Claire E. Dawson, Colin T. Dourish, Suneel Gaur, Allan M. Jordan, Antony R. Knight, Joanne Lerpiniere, Anil Misra, Robert M. Pratt, Jonathan Roffey, Gemma C. Stratton, Rebecca Upton, Scott M. Weiss,